Professional Documents
Culture Documents
Classical Drug Association
Classical Drug Association
Classical Drug Association
DR.SHERIF BADRAWY
Dr. Sherif
Badrawy
Psychosis
1a
levodopa
corticosteroids
1b
Increased risk of
venous
thromboembolism
2a
combined oral
contraceptive pill
tamoxifen
antipsychotics
2b
increased risk of
endometrial cancer
3a
Tamoxifen
3b
Flushing
4a
amlodipine
sildenafil
tamoxifen
4b
Mucositis
5a
methotrexate
fluorouracil (5-FU)
5b
Fluid retention
6a
pioglitazone
ciclosporin
corticosteroids
hydralazine
6b
Peripheral
neuropathy
7a
vincristine,vinblastine,cisplatin
isoniazid
amiodarone
phenytoin
etanercept
7b
haemorrhagic cystitis
8a
Cyclophosphamide
8b
Carbimazole
9a
myelosuppression/agranulocytosis
9b
Primaquine
10a
haemolysis in
patients with G6PD
deficiency
10b
Toxicity in patients
with thiopurine
methyltransferase
deficiency
11a
azathioprine
11b
Thrombocytopaenia
12a
heparin
sodium valproate
thiazides
valproic acid
quinidine
12b
antagonist of the
P2Y12 adenosine
diphosphate (ADP)
receptor
13a
Clopidogrel
13b
acetazolamide
14a
ischaemic heart
disease
15b
tendon damage
16a
Ciprofloxacin
16b
acts as a decoy
receptor for TNFalpha
17a
Etanercept
17b
Prevents microtubule
depolymerisation &
disassembly,
decreasing free tubulin
18a
docetaxel
18b
Inhibits formation of
microtubules
19a
vincristine
19b
Intracranial
hypertension
20a
isotretinoin
corticosteroids
20b
Pulmonary,
retroperitoneal and
cardiac fibrosis
21a
bromocriptine
21b
glucagon-like
peptide-1 mimetic
22a
Exenatide
22b
increased risk of
fractures
23a
Pioglitazone
heparin
bisphosphonates
corticosteroids
23b
asthma
24b
Weight gain
25a
sodium valproate
sulfonylureas
pioglitazone
lithium
antipsychotics
corticosteroids
25b
decreases IL-2
release by inhibiting
calcineurin
26a
Ciclosporin 26b
Causes cross-linking
in DNA
27a
cisplatin
27b
Oculogyric crisis
28a
antipsychotics
metoclopramide
28b
Metformin
Monitoring
29a
review if creatinine is
> 130, stop
metformin if > 150
29b
ACE inhibitors
Monitoring
30a
Acceptable in serum
creatinine , up to 50% from
baseline or up to 265
(whichever is smaller) & an
increase in potassium up to 5.5
30b
oesophagitis
31a
Bisphosphonates
31b
liver fibrosis
32a
Methotrexate
32b
5-HT3 antagonist
33a
Ondansetron 33b
Increased risk of
ischaemic stroke
34a
combined oral
contraceptive pill
antipsychotics
34b
Hypomagnesaemia
35a
cisplatin
35b
torticollis
36a
Antipsychotics
36b
slate-grey appearance
37a
Amiodarone
37b
Anal ulceration
38a
nicorandil
38b
Increased risk of
cervical cancer
39a
39b
recent myocardial
infarction
40b
Aspirin in
breastfeeding
41a
must be avoided
41b
Corneal deposits
42a
amiodarone
antipsychotics
42b
irreversible blockade
of H+/K+ ATPase
43a
Omeprazole 43b
recent myocardial
infarction
44b
Palpitations
45a
levodopa
hydralazine
adenosine
45b
Akathisia (severe
restlessness)
46a
antipsychotics
46b
vancomycin
47b
Epistaxis
48a
isotretinoin (dt
dryness)
warfarin
48b
Reactivation of
tuberculosis
49a
corticosteroids
infliximab
etanercept
49b
recombinant version
of urate oxidase
50a
Rasburicase 50b
Depression
51a
isotretinoin
corticosteroids
levodopa
51b
Hypertrichosis
52a
ciclosporin
minoxidil
52b
Cinchonism
53a
quinidine
53b
Thrombophlebitis
54a
amiodarone
vancomycin
54b
Impotence
55a
thiazides
beta-blockers
55b
Pruritus
56a
opioids
fenofibrate
56b
Hypocalcaemia
57a
loop diuretics
foscarnet
57b
Skin necrosis
58a
warfarin
58b
anticoagulant which
don't cross-react
HIT Abs
59a
Danaparoid
Lepirudin
Argatroban
59b
Oligospermia
60a
sulphasalazine
60b
urinary retention
61a
Tricyclic
antidepressants
antipsychotics
chlorpheniramine
61b
Proximal myopathy
62a
corticosteroids
62b
Hypothyroidism
63a
amiodarone
lithium
carbimazole
63b
ethosuximide
64b
Binds to TNF-alpha
and prevents it from
binding with TNF
receptors
65a
infliximab
65b
Anti-CD20
monoclonal antibody
66a
rituximab
66b
Decreases absorption
of fat-soluble
vitamins
67a
cholestyramine
67b
Osteoporosis
68a
corticosteroids
heparin
pioglitazone
68b
Mania
69a
corticosteroids
69b
Competitive
antagonist of nicotinic
acetylcholine
receptors
70a
atracurium
70b
Myalgia
71a
statins
fenofibrate
71b
Dopamine receptor
agonist
72a
ropinirole
apomorphine
bromocriptine
cabergoline
72b
Acetylcholinesterase
inhibitor
73a
donepezil
pyridostigmine
galantamine
rivastigmine
edrophonium
73b
Denosumab 74b
Insomnia
75a
corticosteroids
75b
Tachycardia
76a
isosorbide
mononitrate
hydralazine
minoxidil
76b
Neuroleptic
malignant syndrome
77a
antipsychotics
77b
Anorexia
78a
levodopa
digoxin
interferon-alpha
78b
Optic neuritis
79a
ethambutol
79b
Non-arteritic anterior
ischaemic neuropathy
80a
sildenafil
80b
coarsening of facial
features
81a
Phenytoin
81b
Pneumonitis
82a
amiodarone
methotrexate
82b
Bronchospasm
83a
beta-blockers
adenosine
83b
Hypertension
84a
corticosteroids
ciclosporin
84b
Inhibits microtubule
polymerization by binding to
tubulin, interfering with
mitosis. Also inhibits
neutrophil motility and activity
85a
colchicine
85b
azathioprine
86b
potassium-channel
activator
87a
Nicorandil 87b
bivalirudin
88a
Reversible direct
thrombin inhibitor
88b
Activates antithrombin
III. Forms a complex that
inhibits thrombin, factors
Xa, Ixa, Xia and XIIa
89a
unfractionated
heparin
89b
Bladder cancer
90a
pioglitazone
90b
Suppression of
growth in children
91a
corticosteroids
91b
Steven-Johnson
syndrome
92a
lamotrigine
carbamazepine
92b
Increased risk of
breast cancer
93a
93b
MAO-B inhibitor
94a
selegiline
94b
COMT inhibitor
95a
entacapone
tolcapone
95b
Inhibits sodium
absorption at the
beginning of the distal
convoluted tubule
96a
bendroflumethiazide
96b
aspirin
97b
Hyperprolactinaemia
98a
antipsychotics
metoclopramide
98b
benzodiazepines
99b
Alopecia
100a
sodium valproate
valproic acid
100b
Increased risk of
myocardial infarction
101a
101b
Constipation
102a
antipsychotics
verapamil
tricyclic antidepressants
opioids
102b
Apomorphine
103a
dopamine receptor
agonist
103b
Retinopathy
104a
hydroxychloroquine
104b
Slurred speech
105a
antipsychotics
phenytoin
amantadine
105b
Gout
106a
thiazides
pyrazinamide
loop diuretics
nicotinic acid
106b
Blurred vision
107a
antipsychotics
tricyclic antidepressants
ivabradine
chlorpheniramine
107b
Gingival hyperplasia
108a
phenytoin
ciclosporin
amlodipine
diltiazem
verapamil
108b
Dyskinesia
109a
levodopa
antipsychotics
phenytoin
109b
Photosensitivity
110a
amiodarone
tetracyclines
isotretinoin
thiazides
110b
Nasal congestion
111a
sildenafil
111b
Ototoxicity
112a
loop diuretics
aminoglycosides
vancomycin
112b
Ataxia
113a
phenytoin
sodium valproate
carbamazepine
amantadine
113b
Dry mouth
114a
isotretinoin
tricyclic antidepressants
levodopa
antipsychotics
chlorpheniramine
114b
Hypoglycaemia
115a
sulfonylureas
meglitinides
115b
Heart failure
116a
verapamil
diltiazem
116b
Dry skin
117a
isotretinoin
117b
Cartilage damage
118a
ciprofloxacin
118b
discolouration of
teeth
120a
Tetracyclines
120b
Osteonecrosis of the
jaw
121a
bisphosphonates
121b
Botox
122b
Heart block
123a
verapamil
diltiazem
ivabradine
adenosine
digoxin
123b
Hirsutism
124a
phenytoin
corticosteroids
124b
growth hormone
receptor antagonist
125a
Pegvisomant 125b
agonist of the A1
receptor in the AV
node
126a
Adenosine 126b
Hypokalaemia
127a
thiazides
loop diuretics
amphotericin B
127b
Stimulates alpha
adrenergic, dopaminergic
and serotonergic receptors
resulting in uterine
contractions
128a
ergometrine
128b
cocaine
129b
Crystalline
nephropathy
130a
aciclovir
130b
Confusion
131a
digoxin
amantadine
phenytoin
metoclopramide
131b
Haemolysis in
patients with G6PD
deficiency
132a
primaquine
ciprofloxacin
sulphonamides
sulphasalazine
sulfonylureas
132b
Meglitinides MOA
133a
increase pancreatic
insulin secretion
133b
non-specific
phosphodiesterase
inhibitor and decreases
cellular uptake of
adenosine
134a
Dipyridamole 134b
Pancreatitis
135a
corticosteroids
sodium valproate
thiazides
valproic acid
135b
Facilitate GABAA
action by increasing the
duration of chloride
channel opening
136a
barbiturates
136b
Yellow-green vision
137a
digoxin
137b
TXA2
138b
Lymphadenopathy
139a
phenytoin
139b
Tremor
140a
lithium
ciclosporin
sodium valproate
antipsychotics
140b
cerebrovascular
disease
141b
Inhibits GABA
transaminase
142a
valproic acid
142b
Increased
susceptibility to
severe infection
143a
corticosteroids
ciclosporin
143b
Hyponatraemia
144a
thiazides
loop diuretics
sulfonylureas
carbamazepine
sodium valproate
144b
Non-specific inhibitor
of phosphodiesterase
resulting in an increase
in cAMP
145a
theophylline
145b
Increases cGMP
leading to smooth
muscle relaxation
146a
isosorbide
mononitrate
hydralazine
146b
Antagonises the
effects of vitamin K
147a
warfarin
147b
Gynaecomastia
148a
spironolactone
148b
Drug-induced lupus
149a
hydralazine
procainamide
hydralazine
phenytoin
carbamazepine
tetracyclines
isoniazid
149b
Disulfiram-like
reaction with alcohol
150a
metronidazole
150b
Nephrotoxicity
151a
ciclosporin
aminoglycosides
amphotericin B
foscarnet
vancomycin
loop diuretics
151b
HER2/neu receptor
antagonist
152a
trastuzumab
152b
Respiratory
depression
153a
benzodiazepines
opioids
153b
Reduced seizure
threshold
154a
ciprofloxacin
antipsychotics
foscarnet
154b
Dizziness
155a
phenytoin
carbamazepine
amantadine
nicorandil
155b
Hyperlipidaemia
156a
isotretinoin
corticosteroids
ciclosporin
protease inhibitors
antipsychotics
156b
Lipodystrophy
157a
protease inhibitors
corticosteroids
157b
Cholesterol gallstones
158a
cholestyramine
fenofibrate
158b
Bradycardia
159a
amiodarone
beta-blockers
digoxin
verapamil
diltiazem
ivabradine
159b